Arquer Diagnostics
@ArquerDx
RT @BladderCancerHU: Learn about an online study that researchers hope will build knowledge that can help people with cancer to be more sat…
Arquer Diagnostics
@ArquerDx
RT @BladderCancerUK: Are you signed up yet to join us for our Virtual Quiz on Friday? Help to raise money for Fight Bladder Cancer and be i… Warning: count(): Parameter must be an array or an object that implements Countable in /home/markbing/public_html/arquerdx.com/wp-content/plugins/accesspress-twitter-feed-pro/inc/frontend/templates/tweet-media.php on line 37
Arquer Diagnostics
@ArquerDx
If you are worried about symptoms of bladder cancer contact your urologist about #ADXBLADDER, a fast, non-invasive test that is able to rule out the presence of the most aggressive #bladder #tumours. https://t.co/3hNKtX8bVR 
Arquer Diagnostics
@ArquerDx
Every single person waiting for a #bladdercancer diagnosis deserves peace of mind that they are cancer-free or can begin vital treatment if required. #Urologists can contact us through to find out how #ADXBLADDER can help. https://t.co/cYChIatuef 
Arquer Diagnostics
@ArquerDx
RT @BladderCancerHU: From the importance of finding a urologist they can trust to finding ways to practice gratitude, #bladdercancer surviv… 
Arquer Diagnostics Announces Exclusive Agreement with SYNLAB to Accelerate the Introduction in the UK of Game-Changing non-invasive Diagnostic test for Patients with Suspected Bladder Cancer
Sunderland, United Kingdom, 13th July 2020 – Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring cancer, today announced that it has entered into an exclusive agreement with SYNLAB UK & Ireland, a leading medical diagnostic services provider.